Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma/leukemia

Acta Haematol. 2012;127(2):115-7. doi: 10.1159/000334705. Epub 2011 Dec 31.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antineoplastic Protocols
  • Burkitt Lymphoma / drug therapy*
  • Burkitt Lymphoma / mortality
  • Female
  • Humans
  • Male
  • Methotrexate / administration & dosage*
  • Middle Aged
  • Retrospective Studies
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Methotrexate